Showing results (131-140 of 162) with videos related to
Sort By:
Pageof 17
European Journal of Immunology|January 3, 2013
CD1d protein structure determines species-selective antigenicity of isoglobotrihexosylceramide (iGb3) to invariant NKT cellsJoseph P Sanderson, Patrick J Brennan, Salah Mansour, et al.Nature Immunology|November 1, 2011
Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signalsPatrick J Brennan, Raju V V Tatituri, Manfred Brigl, et al.Journal of the American Veterinary Medical Association|June 15, 1994
Excretion of porcine reproductive and respiratory syndrome virus in semen after experimentally induced infection in boarsS L Swenson, H T Hill, J J Zimmerman, et al.The Veterinary Record|March 13, 1993
Experimental transmission of an apparent viral pneumonia in conventional and gnotobiotic pigsP G Halbur, P S Paul, J J Andrews, et al.Journal of Medicinal Chemistry|July 6, 2021
Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i)Markus Klein, Michael Busch, Manja Friese-Hamim, et al.Toxicologic Pathology|April 22, 2009
Strain-related differences in urine composition of male rats of potential relevance to urolithiasisSarah H Tannehill-Gregg, Mark A Dominick, Amy J Reisinger, et al.Molecular Cancer Therapeutics|May 28, 2021
M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma ModelsMichael P Sanderson, Manja Friese-Hamim, Gina Walter-Bausch, et al.Toxicologic Pathology|December 21, 2006
Urothelial carcinogenesis in the urinary bladder of male rats treated with muraglitazar, a PPAR alpha/gamma agonist: Evidence for urolithiasis as the inciting event in the mode of actionMark A Dominick, Melvin R White, Thomas P Sanderson, et al.The Journal of Allergy and Clinical Immunology|July 4, 2006
Activation of T cells by carbamazepine and carbamazepine metabolitesYing Wu, Joseph P Sanderson, John Farrell, et al.European Journal of Cancer (Oxford, England : 1990)|May 13, 2021
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor responseOlga Bogatyrova, Johanna S M Mattsson, Edith M Ross, et al.Pageof 17